サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1388185

特殊ジェネリック医薬品市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2032年

Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
特殊ジェネリック医薬品市場、シェア、規模、動向、産業分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年10月23日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの最新調査によると、世界の特殊ジェネリック医薬品市場規模は2032年までに9,480億4,000万米ドルに達する見込みです。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

多くの製薬会社、バイオ医薬品会社、医療機器会社は、他社との合併や買収によって市場でのプレゼンスを拡大することに注力しています。がん、多発性硬化症（MS）、HIVなど、生命を脅かす疾患の蔓延は世界的に増加しており、これが特殊医薬品の需要を促進すると予想されています。特に新興国では、WHOの6地域のうち5地域で慢性疾患が主要な死亡原因となっており、依然として大きな懸念材料となっています。サハラ以南のアフリカではHIVなどの伝染病が依然として蔓延しており、今後も大きな問題であり続けると予想されます。予測期間中、生命を脅かす疾患の高い蔓延により、特殊医薬品市場は急成長が見込まれます。

2020年、COVID-19パンデミックは医薬品市場に大きな影響を与え、いくつかの企業で成長の鈍化と売上高の減少を引き起こしました。製造工場は操業停止に直面し、臨床試験や研究は中止せざるを得ず、熟練労働者の不足が生じた。市場セグメンテーションもそのような企業の1つで、主に競争の激化とパンデミック時の市場シフトによる製品ミックスの変化により、特殊ジェネリック医薬品部門が6.6%減となっています。しかし、2021年には、集団予防接種、立てこもり規制の緩和、慢性疾患治療のための特殊医薬品の需要拡大により、市場は回復の兆しを見せています。

特殊ジェネリック医薬品市場レポートハイライト

予測期間中、注射剤セグメントは医薬品業界で最大かつ最も急成長するセグメントとなる見込みです。これは、効果が長時間持続し、体内への吸収が早いため、患者のコンプライアンスや受容性が高まるためです。新製品の承認が増え、市場が拡大するにつれて、このセグメントは急成長すると予想されます。

2022年、最大の市場シェアを占めたのは炎症性疾患のセグメントでした。関節リウマチのような炎症性疾患の患者数は世界的に増加しています。世界RAネットワークによると、約3,500億人が関節炎と共存しており、NHSは英国で100億人以上が罹患していると報告しています。このような有病率の上昇を受けて、ヘルスケア業界の大手企業はこの分野での市場シェアを拡大しています。

2022年には、専門薬局セグメントが最大の市場シェアを占めました。大手ジェネリック医薬品メーカーや保険業者は、流通コストが低く、医薬品を入手しやすいことから、自社製品の流通を専門薬局に頼ることが多いです。

米国食品医薬品局（FDA）は、新製品の承認を簡素化するための規制政策を実施しています。国民が安全で効果的な低価格ジェネリック医薬品にアクセスできるようにするため、同局はハッチ・ワックスマン法に基づくジェネリック医薬品使用料改正（GDUFA）など、いくつかのイニシアチブを導入しています。その結果、著名なメーカーは常に特殊なジェネリック医薬品の市場導入に取り組んでいます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の特殊ジェネリック医薬品市場に関する洞察

  • 特殊ジェネリック医薬品市場- 最終用途のスナップショット
  • 特殊ジェネリック医薬品市場力学
    • 促進要因と機会
      • 特殊ジェネリック医薬品市場での存在感を拡大する手段として合併・買収を重視する傾向が強まる
      • 市場の成長を促進する特殊医薬品の特許期限切れ
    • 抑制要因と課題
      • 収益性が低く、これらの医薬品に対する認知度が低いため、市場の成長が妨げられる
  • PESTEL分析
  • 特殊ジェネリック医薬品市場の最終用途の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の特殊ジェネリック医薬品市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 注射剤
  • 経口薬
  • その他

第6章 世界の特殊ジェネリック医薬品市場、用途別

  • 主な調査結果
  • イントロダクション
  • 腫瘍
  • 炎症性疾患
  • 多発性硬化症
  • C型肝炎
  • その他

第7章 世界の特殊ジェネリック医薬品市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 専門薬局
  • 小売薬局
  • 病院薬局

第8章 世界の特殊ジェネリック医薬品市場、地域別

  • 主な調査結果
  • イントロダクション
    • 特殊ジェネリック医薬品市場評価、地域別、2019-2032年
  • 特殊ジェネリック医薬品市場-北米
    • 北米：特殊ジェネリック医薬品市場、タイプ別、2019-2032年
    • 北米：特殊ジェネリック医薬品市場、最終用途別、2019-2032年
    • 北米：特殊ジェネリック医薬品市場、用途別、2019-2032年
    • 特殊ジェネリック医薬品市場-米国
    • 特殊ジェネリック医薬品市場- カナダ
  • 特殊ジェネリック医薬品市場- 欧州
    • 欧州：特殊ジェネリック医薬品市場、タイプ別、2019～2032年
    • 欧州：特殊ジェネリック医薬品市場、最終用途別、2019-2032
    • 欧州：特殊ジェネリック医薬品市場、用途別、2019～2032年
    • 特殊ジェネリック医薬品市場- 英国
    • 特殊ジェネリック医薬品市場- フランス
    • 特殊ジェネリック医薬品市場- ドイツ
    • 特殊ジェネリック医薬品市場- イタリア
    • 特殊ジェネリック医薬品市場- スペイン
    • 特殊ジェネリック医薬品市場- オランダ
    • 特殊ジェネリック医薬品市場- ロシア
  • 特殊ジェネリック医薬品市場- アジア太平洋
    • アジア太平洋：特殊ジェネリック医薬品市場、タイプ別、2019～2032年
    • アジア太平洋：特殊ジェネリック医薬品市場、最終用途別、2019～2032年
    • アジア太平洋：特殊ジェネリック医薬品市場、用途別、2019～2032年
    • 特殊ジェネリック医薬品市場- 中国
    • 特殊ジェネリック医薬品市場- インド
    • 特殊ジェネリック医薬品市場- マレーシア
    • 特殊ジェネリック医薬品市場- 日本
    • 特殊ジェネリック医薬品市場- インドネシア
    • 特殊ジェネリック医薬品市場- 韓国
  • 特殊ジェネリック医薬品市場-中東およびアフリカ
    • 中東およびアフリカ：特殊ジェネリック医薬品市場、タイプ別、2019～2032年
    • 中東およびアフリカ：特殊ジェネリック医薬品市場、最終用途別、2019-2032
    • 中東およびアフリカ：特殊ジェネリック医薬品市場、用途別、2019～2032年
    • 特殊ジェネリック医薬品市場- サウジアラビア
    • 特殊ジェネリック医薬品市場-UAE
    • 特殊ジェネリック医薬品市場- イスラエル
    • 特殊ジェネリック医薬品市場- 南アフリカ
  • 特殊ジェネリック医薬品市場-ラテンアメリカ
    • ラテンアメリカ：特殊ジェネリック医薬品市場、タイプ別、2019-2032年
    • ラテンアメリカ：特殊ジェネリック医薬品市場、最終用途別、2019-2032
    • ラテンアメリカ：特殊ジェネリック医薬品市場、用途別、2019-2032年
    • 特殊ジェネリック医薬品市場- メキシコ
    • 特殊ジェネリック医薬品市場- ブラジル
    • 特殊ジェネリック医薬品市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Apotex Corp.
  • Bausch Health Companies Inc.（Valeant Pharmaceuticals International, Inc.）
  • Dr. Reddy's Laboratories Ltd.
  • Endo Pharmaceuticals Inc.
  • Fresenius Kabi Brasil Ltda
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt
  • Novartis AG（Sandoz International GmbH）
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceuticals Industries Ltd
  • Viatris Inc.
図表

List of Tables

  • Table 1 Global Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Specialty Generics Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Specialty Generics Drugs Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Specialty Generics Drugs Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Specialty Generics Drugs Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 12. Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Specialty Generics Drugs Market
目次
Product Code: PM1215

The global specialty generics drugs market size is expected to reach USD 948.04 billion by 2032, according to a new study by Polaris market research. The report "Specialty Generics Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Injectables, Oral Drugs, Others); By Application; By End-use; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Many pharmaceutical, biopharmaceutical, and medical device companies have been focusing on expanding their market presence by merging with or acquiring other companies. The prevalence of life-threatening diseases, such as cancer, Multiple Sclerosis (MS), and HIV, is increasing globally, which is expected to drive the demand for specialty medicines. Chronic diseases remain a major concern, particularly in emerging countries where they are the primary cause of mortality in five of the six WHO regions. Contagious diseases, such as HIV, are still widespread in Sub-Saharan Africa and are expected to continue to be a major issue. During the forecast period, the market for specialty medicines is expected to grow rapidly due to the high prevalence of life-threatening diseases.

In 2020, the COVID-19 pandemic had a significant impact on the pharmaceutical market, causing slower growth and a decline in net sales for several companies. Manufacturing plants had to face lockdown restrictions, clinical trials and studies had to be stopped, and there was a shortage of skilled labor. Mallinckrodt is one such company that experienced a -6.6% decline in its specialty generics segment, mainly due to increased competition and a change in product mix caused by market shifts during the pandemic. However, the market is showing signs of recovery in 2021, with mass vaccinations, easing of lockdown restrictions, and a growing demand for specialty medicines to treat chronic conditions.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Specialty generics drugs Market Report Highlights

During the forecast period, the Injectables segment is expected to be the largest and fastest-growing segment in the pharmaceutical industry. This is due to its ability to have long-lasting effects and quick absorption into the body, resulting in higher patient compliance and acceptance. With the increased approvals of new products and the expansion of the market, the segment is anticipated to grow rapidly.

In 2022, the largest market share was held by the segment of inflammatory conditions. The number of individuals with inflammatory conditions like rheumatoid arthritis is increasing globally. According to the Global RA Network, around 350 Billion people are living with arthritis, while the NHS has reported that over 10 Billion people in the UK are affected. In response to this rise in prevalence, major players in the healthcare industry are expanding their market share in this sector.

In 2022, the organic segment had the largest share. Organic bread improvers are made from organic ingredients and produced using organic farming methods. This means they are free from synthetic chemicals and GMOs. These organic improvers contain natural additives sourced from organic materials.

In 2022, the specialty pharmacy segment held the largest market share. Major generic manufacturers and insurance providers often rely on specialty pharmacies to distribute their products because of the low distribution costs and the easy accessibility of medicines offered by these pharmacies.

The US Food and Drug Administration (FDA) has implemented supportive regulatory policies to simplify the approval of new products. In order to make sure the public has access to safe and effective low-cost generic drugs, the agency has put several initiatives in place, including the Generic Drug User Fee Amendments (GDUFA) under the Hatch-Waxman Act. Consequently, prominent manufacturers are constantly working to introduce specialty generic drugs to the market.

The global key market players include: Apotex Corp., Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.), Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Fresenius Kabi Brasil Ltda, Hikma Pharmaceuticals PLC, Mallinckrodt, Novartis AG (Sandoz International GmbH)

Polaris market research has segmented the Speciality generics drugs market report based on type, application, end-user, and region:

Specialty generics drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Injectables
  • Oral Drugs
  • Others

Specialty generics drugs, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Inflamatory conditions
  • Multiple sclerosis
  • Hepatitis C
  • Others

Speciality generics drugs, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Specialty pharmacy
  • Retail pharmacy
  • Hospital pharmacy

Speciality generics drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Specialty Generics Drugs Market Insights

  • 4.1. Specialty Generics Drugs Market - End-Use Snapshot
  • 4.2. Specialty Generics Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing emphasizing mergers and acquisitions as a means of expanding their presence in the specialty generics market
      • 4.2.1.2. The expiration of patents on specialty drugs to drive the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Low profitability and lack of awareness about these drugs, hinder the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Specialty Generics Drugs Market End-Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Specialty Generics Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Injectables
    • 5.3.1. Global Specialty Generics Drugs Market, by Injectables, by Region, 2019-2032 (USD Billion)
  • 5.4. Oral Drugs
    • 5.4.1. Global Specialty Generics Drugs Market, by Oral Drugs, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Specialty Generics Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Specialty Generics Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Specialty Generics Drugs Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 6.4. Inflamatory conditions
    • 6.4.1. Global Specialty Generics Drugs Market, by Inflamatory conditions, by Region, 2019-2032 (USD Billion)
  • 6.5. Multiple sclerosis
    • 6.5.1. Global Specialty Generics Drugs Market, by Multiple sclerosis, by Region, 2019-2032 (USD Billion)
  • 6.6. Hepatitis C
    • 6.6.1. Global Specialty Generics Drugs Market, by Hepatitis C, by Region, 2019-2032 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Specialty Generics Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Specialty Generics Drugs Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3. Specialty pharmacy
    • 7.3.1. Global Specialty Generics Drugs Market, by Specialty pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.4. Retail pharmacy
    • 7.4.1. Global Specialty Generics Drugs Market, by Retail pharmacy, By Region, 2019-2032 (USD Billion)
  • 7.5. Hospital pharmacy
    • 7.5.1. Global Specialty Generics Drugs Market, by Hospital pharmacy, By Region, 2019-2032 (USD Billion)

8. Global Specialty Generics Drugs Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Specialty Generics Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Specialty Generics Drugs Market - North America
    • 8.3.1. North America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Specialty Generics Drugs Market - U.S.
      • 8.3.4.1. U.S.: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Specialty Generics Drugs Market - Canada
      • 8.3.5.1. Canada: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Specialty Generics Drugs Market - Europe
    • 8.4.1. Europe: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Specialty Generics Drugs Market - UK
      • 8.4.4.1. UK: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Specialty Generics Drugs Market - France
      • 8.4.5.1. France: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Specialty Generics Drugs Market - Germany
      • 8.4.6.1. Germany: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Specialty Generics Drugs Market - Italy
      • 8.4.7.1. Italy: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Specialty Generics Drugs Market - Spain
      • 8.4.8.1. Spain: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Specialty Generics Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Specialty Generics Drugs Market - Russia
      • 8.4.10.1. Russia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Specialty Generics Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Specialty Generics Drugs Market - China
      • 8.5.4.1. China: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Specialty Generics Drugs Market - India
      • 8.5.5.1. India: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Specialty Generics Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Specialty Generics Drugs Market - Japan
      • 8.5.7.1. Japan: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Specialty Generics Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Specialty Generics Drugs Market - South Korea
      • 8.5.9.1. South Korea: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Specialty Generics Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Specialty Generics Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Specialty Generics Drugs Market - UAE
      • 8.6.5.1. UAE: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Specialty Generics Drugs Market - Israel
      • 8.6.6.1. Israel: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Specialty Generics Drugs Market - South Africa
      • 8.6.7.1. South Africa: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Specialty Generics Drugs Market - Latin America
    • 8.7.1. Latin America: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Specialty Generics Drugs Market - Mexico
      • 8.7.4.1. Mexico: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Specialty Generics Drugs Market - Brazil
      • 8.7.5.1. Brazil: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Specialty Generics Drugs Market - Argentina
      • 8.7.6.1. Argentina: Specialty Generics Drugs Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Specialty Generics Drugs Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Specialty Generics Drugs Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Apotex Corp.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dr. Reddy's Laboratories Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Endo Pharmaceuticals Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fresenius Kabi Brasil Ltda
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hikma Pharmaceuticals PLC
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG (Sandoz International GmbH)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. STADA Arzneimittel AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10.Sun Pharmaceutical Industries Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Teva Pharmaceuticals Industries Ltd
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Viatris Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development